But even these patients benefit from advances against cancer, the report said. Five-year survival rates have increased since ...
Explore the groundbreaking project to develop a 3D bioprinted liver, potentially changing the future of organ transplants.
Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita ...
For the first time, the five-year relative survival rate for all cancers combined reached 70%, according to the latest report ...
Large language models (LLM) can generate treatment recommendations for straightforward cases of hepatocellular carcinoma (HCC ...
Scientists have discovered that blocking a key cellular enzyme thought to protect against fatty liver disease may instead increase the risk of chronic liver damage and cancer as we age.